Sign in
Taking peoplePhase 2

The Effect of Dormicum-Ketamine Versus Dexmedetomidine on Emergence Delirium During Deep Sedation in Paediatric Burn Patients

Key facts

Who runs it
Ain Shams University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
Phase
Phase 2
People taking part
60 people, planned
Started
20 Nov 2025
Expected to end
Dec 2026
Type of study
Interventional, 2 groups
Treatments tested
  • Midazolam + Ketamine
  • Dexmedetomidine (DEX)
Record updated
9 April 2026

Who can take part

Age
3 years to 16 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Age from 3 to 16 years
  • Both sexes
  • Patients classified as American Society of Anesthesiologists (ASA) Physical -Status I-II
  • Patients scheduled for elective burn-related procedures (e.g., burn dressing changes or minor interventions)

Who cannot take part

  • Patients receiving or requiring high doses of inotropes and/or vasopressors intraoperatively or postoperatively
  • Known allergy or hypersensitivity to any of the study medications (midazolam, ketamine, or dexmedetomidine)
  • Presence of immunological or hematological disorders
  • History of epilepsy, developmental delay (mental retardation), or neurological deficits
  • Preoperative hemodynamic instability, defined as uncontrolled hypertension, hypotension, or bradycardia
  • Refusal or inability to provide written informed consent from parent or legal guardian
  • Presence of hepatic dysfunction
  • Presence of renal dysfunction

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 3 and 16 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this study is to compare the effects of dormicum-ketamine versus dexmedetomidine on postoperative emergence delirium in pediatric patients undergoing deep sedation for burn-related procedures

The 2 groups in the trial

  • Midazolam - Ketamine GroupTreatment being tested

    Drug

    Treatment: Midazolam + Ketamine

  • DexmedetomidineTreatment being tested

    Drug

    Treatment: Dexmedetomidine (DEX)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT07519863, who can take part
Record updated
9 April 2026